Document is current
Any future updates will be listed below
-
Authors
Roncaglia, Eleonora
Gaffo, Enrico
Calabretto, Giulia
Fürstenau, Moritz
Rogers, Kerry A.
Baliakas, Panagiotis
Cui, Chenghua
Miller, Cecelia
Haferlach, Claudia
Plevova, Karla
Oscier, David
Davis, Zadie
Nguyen-Khac, Florence
Rigolin, Gian Matteo
Athanasiadou, Anastasia
Baran-Marszak, Fanny
Valiente, Alberto
Terol, Maria José
Abrisqueta, Pau
Espinet, Blanca
Puiggros, Anna
Martines, Annalisa
Bonaldi, Laura
Mauro, Francesca Romana
Scarfò, Lydia
Chatzikonstantinou, Thomas
Tausch, Eugen
Kreuzer, Karl-Anton
Kater, Arnon
Bosch, Francesc
Doubek, Michael
Panagiotidis, Panagiotis
Kalashnikova, Olga
Frezzato, Federica
Ruocco, Valeria
Orsi, Silvia
Salek, Kimia
Merlo, Roberto
Caregari, Alberto
Glogovitis, Ilias
Cellini, Alessandro
Angotzi, Francesco
Serafin, Andrea
Yi, Shuhua
Eichhorst, Barbara
Woyach, Jennifer A.
Cuneo, Antonio
Ghia, Paolo
Stamatopoulos, Kostas
Trentin, Livio
Visentin, Andrea
Bortoluzzi, Stefania
- License Information
-
More Information
Article History
Received: 15 April 2025
Accepted: 3 July 2025
First Online: 22 July 2025
Declarations
:
: The study was conducted according to the Declaration of Helsinki, approved by the ethics committee of the Padova University Hospital (protocol # 4430/AO/18), and informed consents were collected.
: AV, LT, PG, LS, AC, and FRM attended scientific boards organized by Johnson & Johnson, AstraZeneca, BeiGene, and AbbVie. PG received honoraria from AbbVie, AstraZeneca, BeiGene, BMS, Galapagos, Johnson & Johnson, Lilly/Loxo, MSD, Roche, and research funding from AbbVie, AstraZeneca, BeiGene, BMS, Johnson & Johnson, Lilly/Loxo, MSD. LS received honoraria from AbbVie, AstraZeneca, BeiGene, Johnson & Johnson, Lilly, and MSD. The other authors declared no potential conflict of interest with this study.
